Papers/PMID:30835085
Oral Magnesium Supplementation Improved Lipid Profile but Increased Insulin Resistance in Patients with Diabetic Nephropathy: a Double-Blind Randomized Controlled Clinical Trial.
Biological trace element research2020The record
2 findings · 1 compound · 2 endpoints · 2 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
2 findings
magnesium(2+) — no detected effect on serum creatinine concentration
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Furthermore, magnesium did not affect inflammation, serum levels of creatinine, and blood urine nitrogen.”
Quoted verbatim from Oral Magnesium Supplementation Improved Lipid Profile but Increased Insulin Resistance in Patients with Diabetic Nephropathy: a Double-Blind Randomized Controlled Clinical Trial.. - Study
- RCT
- Duration
- 3 months
- Dose
- daily magnesium oxide, dose not stated in abstract, 12 weeks
- Population
- Hypomagnesemic patients with type 2 diabetes and early-stage nephropathy; magnesium oxide versus placebo
Oral Magnesium Supplementation Improved Lipid Profile but Increased Insulin Resistance in Patients with Diabetic Nephropathy: a Double-Blind Randomized Controlled Clinical Trial.2020PMID:30835085Permalink
magnesium(2+) — no detected effect on blood urea nitrogen
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Furthermore, magnesium did not affect inflammation, serum levels of creatinine, and blood urine nitrogen.”
Quoted verbatim from Oral Magnesium Supplementation Improved Lipid Profile but Increased Insulin Resistance in Patients with Diabetic Nephropathy: a Double-Blind Randomized Controlled Clinical Trial.. - Study
- RCT
- Duration
- 3 months
- Dose
- daily magnesium oxide, dose not stated in abstract, 12 weeks
- Population
- Hypomagnesemic patients with type 2 diabetes and early-stage nephropathy; magnesium oxide versus placebo
Oral Magnesium Supplementation Improved Lipid Profile but Increased Insulin Resistance in Patients with Diabetic Nephropathy: a Double-Blind Randomized Controlled Clinical Trial.2020PMID:30835085Permalink